@kkarhan ADHD medicines are often seen as being particularly needful of flat relese profiles, so, naturally, somebody also did transdermal methylphenidate patches. But it was never approved in Europe, and from what I hear, might have been stopped being marketed in USA, as well. (As far as I can tell, for market reasons, with a wee bit of involvement from the War On Drugs, not because it was a bad way to deliver the medicine.)SleepyCatten@cultofshiv.wtf
